NEW DELHI — As British-Swedish pharma giant AstraZeneca recalled its Covid-19 vaccine globally, Pune-based Serum Institute of India (SII) on Wednesday said it stopped the...

New Delhi, Jan. 25 (PTI): A booster dose of Covishield offers the best immune response, irrespective of whether the primary doses were of Covishield or...

New Delhi, Jan. 7 (PTI): Neutralising antibody responses against the SARS-COV-2 virus and its variants of concern (VoC) are higher among Covishield recipients than those...

New Delhi, March 20 (IANS): The National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap between the first and second dose of...

New Delhi, Jan. 27 (PTI): India’s drug regulator has granted regular market approval for Covid-19 vaccines Covishield and Covaxin for use in the adult population...

Payal Banerjee | PTI An expert panel of India’s central drug authority on Thursday recommended granting permission to the Christian Medical College (CMC) in Vellore...

New Delhi, May 30 (PTI): Serum Institute of India (SII) has informed the government that it will be able to manufacture and supply nine to...

New Delhi, March 22 (IANS): India has decided to extend the interval between doses of Covishield vaccines from four to eight to four to eight...

Dimapur, Feb. 25 (EMN): As many as 34,075 doses of Covishield vaccine have been administered to healthcare and frontline workers across the state till date...

Our CorrespondentKohima, Jan. 14 (EMN): Dimapur district will receive highest number of Covishield doses with 6640 and Longleng will receive the least with 660, according...